Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -45066.67% is 48% below its 5-year average of -30393.39%, around the middle of its 5-year range (-89540.00%–0.00%).
25.06% above its 12-month average of -60138.47%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -33346.67%.
OPERATING MARGIN
-45066.67%
OPERATING MARGIN AVG TTM
-60138.47%
OPERATING MARGIN AVG 3Y
-37196.08%
OPERATING MARGIN AVG 5Y
-30393.39%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+25.06%
CURRENT VS 3Y AVG
-21.16%
CURRENT VS 5Y AVG
-48.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sera Prognostics, Inc.
Market Cap
$78.29M
Operating Margin
-45066.67%
TTM Avg
-60138.47%
3Y Avg
-37196.08%
5Y Avg
-30393.39%
Market Cap
$78.07M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
Market Cap
$78.59M
Operating Margin
0.00%
TTM Avg
-1188.79%
3Y Avg
-873.63%
5Y Avg
-703.36%
Market Cap
$79.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$77.54M
Operating Margin
-145459.36%
TTM Avg
-145459.36%
3Y Avg
-145459.36%
5Y Avg
-145459.36%
Market Cap
$79.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$76.74M
Operating Margin
-56.06%
TTM Avg
-77.78%
3Y Avg
-106.34%
5Y Avg
-131.30%
Market Cap
$80.30M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$75.95M
Operating Margin
-1.49%
TTM Avg
-13.59%
3Y Avg
-16.79%
5Y Avg
-16.15%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $78.29M | -45066.67% | -60138.47% | -37196.08% | -30393.39% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | 0.00% | -1188.79% | -873.63% | -703.36% |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -145459.36% | -145459.36% | -145459.36% | -145459.36% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outset Medical, Inc. (OM)vs › | $76.74M | -56.06% | -77.78% | -106.34% | -131.30% |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | -1.49% | -13.59% | -16.79% | -16.15% |
| Nutriband Inc. (NTRB)vs › | $81.20M | -408.41% | -360.51% | -288.53% | -284.25% |
Gross Margin
-102.5%
Operating Margin
-45066.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -33346.67% |
| 2026-03-31 | -66857.14% |
| 2025-12-31 | -89540.00% |
| 2025-09-30 | -56125.00% |
| 2025-06-30 | -54823.53% |
| 2025-03-31 | -24342.11% |
| 2024-12-31 | -39262.50% |
| 2024-09-30 | -30558.62% |
| 2024-06-30 | -38554.17% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -21336.59% |
| 2023-09-30 | -19485.71% |
| 2023-06-30 | -9317.07% |
| 2023-03-31 | -11329.00% |
| 2022-12-31 | -16027.69% |
| 2022-09-30 | -12859.77% |
| 2022-06-30 | -15058.97% |
| 2022-03-31 | -32368.42% |
| 2021-12-31 | -48257.69% |
| 2021-09-30 | -41052.17% |
| 2021-06-30 | -36905.00% |
| 2021-03-31 | -46346.15% |
| 2020-12-31 | -79233.33% |
| 2020-09-30 | -92880.00% |
| 2020-06-30 | -71350.00% |
| 2020-03-31 | -53650.00% |
